[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Insider purchases by Precigen CFO increased his stake in the company. Harry Thomasian Jr. acquired 8,284 shares on 09/25/2025 at a weighted average price of $3.62 and 2,932 shares on 09/26/2025 at $3.42, bringing his total beneficial ownership to 468,626 shares. The filing shows the transactions were reported on Form 4 and the price for the 09/25 purchases is a weighted average of trades between $3.53 and $3.67. The report was signed on 09/26/2025 by an attorney-in-fact on behalf of the reporting person.

Positive

• Officer purchases: Chief Financial Officer Harry Thomasian Jr. bought 11,216 shares on 09/25-09/26/2025
• Increased beneficial ownership: Total beneficial ownership rose to 468,626 shares
• Detailed pricing disclosure: 09/25 trades reported with a weighted average price and disclosed price range ($3.53–$3.67)

Negative

• None.

Insights

Securities Analyst

TL;DR: Company CFO made open-market purchases that modestly increased his stake.

The filing documents direct open-market purchases by the Chief Financial Officer totaling 11,216 shares across two dates, increasing beneficial ownership to 468,626 shares. The 09/25 transaction reports a weighted average price and the filer discloses the price range for those trades. From a disclosure perspective the Form 4 provides the standard level of detail required for Section 16 reporting and includes the attestation signature by an attorney-in-fact.

Corporate Governance Expert

TL;DR: Transparent reporting of insider transactions with required price-range disclosure.

The report identifies the reporting person as an officer (Chief Financial Officer) and documents purchases made in the open market with a clear footnote on weighted average pricing. The Form 4 includes the reporting person’s address and the required signature. No amendments, dispositions, derivative transactions, or other conditions are disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Thomasian Harry Jr.

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		P		8,284	A	$3.62(1)	465,694	D
Common Stock	09/26/2025		P		2,932	A	$3.42	468,626	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

	/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did PGEN report on this Form 4?

The CFO purchased 8,284 shares on 09/25/2025 and 2,932 shares on 09/26/2025, totaling 11,216 shares.

What prices were paid for the PGEN shares in the Form 4?

09/25 purchases: weighted average $3.62 (trades ranged $3.53–$3.67); 09/26 purchases: $3.42.

How many PGEN shares does the reporting person beneficially own after these transactions?

468,626 shares beneficially owned following the reported transactions.

Who filed the Form 4 on behalf of the reporting person?

The filing was signed by Harry Thomasian Jr. via attorney-in-fact Donald P. Lehr on 09/26/2025.

Does the Form 4 report any derivative transactions or dispositions?

No. The filing shows only non-derivative acquisitions and no dispositions or derivative securities.